Aged-Related Changes in Microglia and Neurodegenerative Diseases: Exploring the Connection

Borrajo Ana1

  • 1Department of Microbiology and Parasitology, Faculty of Pharmacy, Complutense University of Madrid, 28040 Madrid, Spain.

Biomedicines
|August 29, 2024
PubMed

Insights

Aging alters microglial cells, shifting them toward a neurotoxic state and promoting neurodegeneration. Understanding these inflammatory and metabolic changes is key for developing new therapies for brain diseases.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglial cells, the immune cells of the central nervous system, share similarities with macrophages.
  • Aging significantly impacts microglial cell function, promoting a pro-inflammatory and neurotoxic phenotype.
  • Dysregulated microglial pathways and neuron interactions are implicated in chronic activation and neurodegeneration.

Purpose of the Study:

  • To review the role of microglial cell aging in neuroinflammation and neurodegeneration.
  • To explore the metabolic shifts in aged microglia, specifically the downregulation of oxidative phosphorylation.
  • To highlight the importance of understanding microglial mechanisms for therapeutic development.

Main Methods:

  • Literature review focusing on microglial cell biology, aging, and neurodegenerative diseases.
  • Analysis of studies detailing microglial polarization and inflammatory marker expression.
  • Examination of research on metabolic changes in aged microglia, including energy production pathways.

Main Results:

  • Aging skews microglial polarization towards a neurotoxic phenotype with increased pro-inflammatory markers.
  • Chronic activation and neurodegeneration are linked to dysregulated microglial regulatory pathways and neuronal interactions.
  • Aged microglia exhibit metabolic alterations, notably reduced oxidative phosphorylation.

Conclusions:

  • Microglial cell aging is a critical factor in neuroinflammation and the progression of neurodegenerative diseases like Alzheimer's and Parkinson's.
  • Targeting microglial inflammatory and metabolic dysregulation offers potential for novel therapeutic strategies.
  • Further research into microglial mechanisms is essential for advancing preventive and treatment approaches for neurological disorders.